Institutional investors purchased a net $396.3 thousand shares of MRNA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 63.36% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 842.7 Thousand shares of Moderna Inc
MORGAN STANLEY & CO. LLC Bought 834.3 Thousand shares of Moderna Inc
TWO SIGMA INVESTMENTS LP Bought 627.0 Thousand shares of Moderna Inc